Ophthalmic World Leaders (OWL) has unveiled its 2025 Leadership Award recipients. The honorees are recognized for driving ...

To celebrate Ophthalmology Times' 50th anniversary, we asked leading experts what the practice would look like today had ...

To explore the implications of this latest approval and what it means for US surgeons and their patients, the Eye Care ...

Joel S. Schuman, MD, FACS, of Wills Eye Hospital, presented an update on laser therapies for glaucoma, emphasizing recent ...

David Eichenbaum, MD, FASRS, recalls an early-career case managing bilateral diabetic macular edema with frequent ...

A recent Ophthalmology Times Case-Based Roundtable addressed the pathway to achieving optimized visual outcomes using an ...

Andrew G. Lee, MD, revisits a 1997 case in which recognizing paraneoplastic optic neuropathy led to the diagnosis—and life-saving treatment—of small cell lung carcinoma.

Two sustained-release procedural pharmaceuticals or drug-delivery options are available in the US: the bimatoprost ...

Five systemic drugs, including fingolimod and apixaban, were identified with under-recognized maculopathy risks using ...

Neda Shamie, MD, recounts a humbling experience performing cataract surgery in Honduras using older-generation phaco machines ...

Proactive strategies in glaucoma care, including minimally invasive glaucoma surgery (MIGS) and physician decision-making, ...

The FDA issued a complete response letter for SYD-101, citing insufficient evidence of effectiveness despite achieving ...